Nicotinell Med Lakrissmak

Nicotine, the active ingredient in Nicotinell Med Lakrissmak, is a nicotinic agonist presented as a buccal formulation for use. It is indicated for smoking cessation and helps adult smokers manage nicotine withdrawal. GNH USA supplies Nicotinell Med Lakrissmak as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies worldwide.

Nicotinell Med Lakrissmak, a nicotinic agonist, is used in the management of nicotine dependence and related conditions.

- Smoking cessation: Helps adult smokers reduce cravings and withdraw from nicotine. - Tobacco dependence: Supports individuals attempting to quit all forms of tobacco use. - Relapse prevention: Aids in maintaining abstinence after quitting.

Nicotinell Med Lakrissmak may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Hiccups - Headache - Dizziness - Increased salivation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Chest pain or palpitations - Hypertension - Cardiac arrhythmia - Respiratory distress - Persistent vomiting

When using Nicotinell Med Lakrissmak, consider the following precautions to ensure safe use.

- Assess suitability: evaluate cardiovascular status before initiating. - Avoid use in uncontrolled hypertension: monitor blood pressure closely. - Do not combine with other nicotine replacement products simultaneously. - Discontinue if severe irritation or allergic reaction occurs. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotinell Med Lakrissmak can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Other nicotine replacement therapies: risk of nicotine overdose. - CYP2A6 inhibitors: may alter nicotine metabolism.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): monitor for increased side effects. - Beta‑blockers: may mask tachycardia. - Antihypertensives: monitor blood pressure.